Skip to main content
. 2011 Aug 16;105(6):737–745. doi: 10.1038/bjc.2011.315

Table 2. Late symptoms during the past 6 months among gynaecological cancer survivors treated with pelvic radiation therapy with or without surgery and control women.

  Survivors, N=616 (%) Controls, N=344 (%) Survivors vs controls Age-adjusted RR (95% CI ) RT with surgery, N=549 (%) RT with surgery vs controls Age-adjusted RR (95% CI) RT without surgery, N=67 (%) RT without surgery vs controls Age-adjusted RR (95% CI)
Anal-sphincter symptoms
 Emptying of all stools into clothing without forewarning at least occasionally 70/606 (12) 3/344 (0.9) 12.7 (4.0–40.3) 55/546 (10) 8.8 (2.8–28.3) 15/60 (25) 30.3 (9.1–101.1)
 Leakage of loose stools while awake at least occasionally 199/608 (33) 18/344 (5) 6.0 (3.7–9.6) 171/545 (31) 5.5 (3.4–8.8) 28/63 (44) 8.5 (5.0–14.5)
 Leakage of loose stools while asleep at least occasionally 72/611 (12) 8/343 (2) 5.5 (2.6–11.4) 58/548 (11) 4.4 (2.1–9.2) 14/63 (22) 9.8 (4.3–22.4)
 Anal leakage of mucus while asleep at least occasionally 32/607 (5) 4/344 (1) 4.9 (1.7–14.1) 25/545 (5) 3.3 (1.1–9.4) 7/62 (11) 9.7 (2.9–32.3)
 Leakage of solid stools while awake at least occasionally 46/607 (8) 5/344 (1) 4.4 (1.7–11.0) 37/544 (7) 3.4 (1.4–8.7) 9/63 (14) 9.3 (3.2–27.0)
 Faecal leakage without forewarning despite previous defaecation at least occasionally 188/605 (31) 23/344 (7) 4.2 (2.8–6.4) 168/545 (31) 3.9 (2.6–6.0) 20/60 (33) 4.8 (2.8–8.2)
 Defaecation urgency with faecal leakage at least occasionally 298/603 (49) 42/343 (12) 4.0 (3.0–5.4) 262/541 (48) 3.8 (2.8–5.2) 36/62 (58) 4.8 (3.3–6.8)
 Foul smelling flatulence at least once a week 116/602 (19) 22/343 (6) 3.7 (2.4–5.8) 102/541 (19) 3.8 (2.4–5.9) 14/61 (23) 3.6 (2.0–6.7)
 Anal leakage of mucus while awake at least occasionally 87/603 (14) 14/343 (4) 3.5 (2.0–6.1) 76/542 (14) 3.2 (1.8–5.6) 11/61 (18) 4.1 (1.9–8.6)
 Self-perception of faecal odour at least occasionally 108/606 (18) 18/340 (5) 3.3 (2.0–5.4) 95/544 (17) 3.1 (1.9–5.2) 13/62 (21) 4.0 (2.1–7.8)
 Involuntary flatulence at least once a week 127/606 (21) 33/343 (10) 2.4 (1.7–3.5) 111/545 (20) 2.3 (1.5–3.3) 16/61 (26) 2.8 (1.7–4.8)
 Unwanted defaecation while emptying bladder at least occasionally 238/603 (39) 57/342 (17) 2.4 (1.9–3.2) 213/541 (39) 2.4 (1.8–3.1) 25/62 (40) 2.3 (1.6–3.4)
 Anal leakage of blood while awake at least occasionally 42/608 (7) 12/343 (4) 2.0 (1.1–3.9) 37/545 (7) 2.0 (1.0–3.9) 5/63 (8) 2.2 (0.8–6.7)
 Involuntary loud flatulence at least occasionally 359/607 (59) 150/344 (44) 1.4 (1.2–1.6) 314/546 (58) 1.3 (1.1–1.5) 45/61 (74) 1.7 (1.4–2.1)
               
Bowel symptoms
 Defaecation urgency at least once a week 175/602 (29) 19/341 (6) 5.7 (3.5–9.1) 157/542 (29) 5.7 (3.5–9.1) 18/60 (30) 6.0 (3.3–10.8)
 Protracted abdominal pain lasting >1 year, yes 69/593 (12) 15/339 (4) 3.2 (1.9–5.6) 59/532 (11) 3.1 (1.7–5.5) 10/61 (16) 3.8 (1.8–7.9)
 Loose stools at least once a week 234/602 (39) 48/344 (14) 3.0 (2.2–3.9) 205/540 (38) 2.9 (2.1–3.9) 29/62 (47) 3.5 (2.4–5.1)
 Abdominal pain and vomiting at least occasionally 60/605 (10) 13/344 (4) 2.6 (1.4–4.7) 49/545 (9) 2.2 (1.2–4.1) 11/60 (18) 4.8 (2.2–10.1)
 Mucus in stools at least occasionally 156/607 (26) 45/343 (13) 2.1 (1.5–3.0) 143/545 (26) 2.2 (1.6–3.0) 13/62 (21) 1.6 (0.9–2.8)
 Abdominal bloating at least once a week 147/605 (24) 60/342 (18) 1.8 (1.4–2.3) 129/544 (24) 1.8 (1.3–2.3) 18/61 (30) 1.8 (1.1–2.7)
 Rectal bleeding at least occasionally 103/604 (17) 42/341(12) 1.6 (1.1–2.2) 92/545 (17) 1.6 (1.2–2.4) 11/59 (19) 1.5 (0.8–2.8)
 Abdominal pain and stools at least occasionally 198/602 (33) 79/343 (23) 1.6 (1.3–2.0) 171/541 (32) 1.5 (1.2–1.9) 27/61 (44) 2.0 (1.4–2.8)
 Abdominal pain at least occasionally 307/604 (51) 137/340 (40) 1.4 (1.2–1.6) 272/544 (50) 1.4 (1.2–1.6) 35/60 (58) 1.5 (1.2–1.9)
 Abdominal pain and bloating at least occasionally 228/603 (38) 106/340 (31) 1.4 (1.2–1.7) 199/542 (37) 1.4 (1.2–1.7) 29/61 (48) 1.6 (1.2–2.1)
               
Urinary tract symptoms
 Difficulty feeling the need to empty bladder at least occasionally 56/604 (9) 11/343 (3) 2.8 (1.5–5.4) 46/544 (8) 2.5 (1.3–5.0) 10/60 (17) 5.1 (2.3–11.3)
 Difficulty emptying bladder at least occasionally 49/602 (8) 11/343 (3) 2.7 (1.4–5.2) 43/542 (8) 2.7 (1.4–5.5) 6/60 (10) 3.2 (1.3–8.4)
 Difficulty feeling full bladder at least occasionally 90/602 (15) 18/342 (5) 2.7 (1.6–4.5) 76/543 (14) 2.4 (1.4–4.1) 14/59 (24) 4.5 (2.4–8.4)
 Haematuria at least occasionally 20/606 (3) 5/344 (1) 2.5 (0.9–6.9) 16/546 (3) 2.4 (0.8–6.8) 4/60 (7) 5.0 (1.4–17.8)
 Straining to initiate emptying of bladder at least occasionally 77/605 (13) 21/343 (6) 2.2 (1.4–3.7) 68/545 (12) 2.4 (1.5–3.9) 9/60 (15) 2.5 (1.2–5.3)
 Painful emptying of bladder at least occasionally 60/605 (10) 20/341 (6) 2.0 (1.2–3.3) 52/545 (10) 1.9 (1.1–3.3) 8/60 (13) 2.3 (1.1–5.0)
 Urinary incontinence without urinary urgency at least occasionally 88/603 (15) 24/342 (7) 1.8 (1.2–2.9) 81/543 (15) 1.9 (1.2–3.0) 7/60 (12) 1.6 (0.7–3.6)
 Night-time emptying of bladder at least twice per night or more, yes 222/607 (37) 58/341 (17) 1.8 (1.4–2.4) 199/548 (36) 1.8 (1.4–2.4) 23/59 (39) 2.2 (1.5–3.2)
 Need of antibiotics because of urinary tract infection twice or more, yes 93/605 (15) 31/344 (9) 1.6 (1.1–2.3) 86/545 (16) 1.7 (1.1–2.5) 7/60 (12) 1.3 (0.6–2.9)
 Urinary incontinence because of urinary urgency at least occasionally 209/607 (34) 66/342 (19) 1.6 (1.2–2.0) 186/545 (34) 1.5 (1.2–2.0) 23/62 (37) 1.8 (1.2–2.7)
 Slow emptying of bladder at least occasionally 122/605 (20) 47/344 (14) 1.6 (1.2–2.2) 106/546 (19) 1.5 (1.1–2.2) 16/59 (27) 2.0 (1.2–3.3)
 Self-perception of urine odour at least occasionally 149/605 (25) 62/341(18) 1.4 (1.1–1.9) 126/544 (23) 1.3 (1.0–1.8) 23/61 (38) 2.1 (1.4–3.0)
 Urinary urgency at least occasionally 346/605 (57) 139/343 (41) 1.3 (1.1–1.5) 308/544 (57) 1.3 (1.1–1.5) 38/61 (62) 1.5 (1.2–1.8)
 Feeling of incomplete bladder emptying at least occasionally 232/604 (38) 101/343 (29) 1.3 (1.1–1.6) 203/544 (37) 1.3 (1.0–1.6) 29/60 (48) 1.6 (1.2–2.2)
               
Symptoms related to sexuality
 Protracted genital pain lasting for >1 year, yes 28/593 (5) 4/339 (1) 5.0 (1.7–14.5) 21/532 (4) 4.3 (1.4–13.0) 7/61 (11) 9.6 (2.9–31.8)
 Genital bleeding during or after intercourse at least once, yes 54/585 (9) 13/329 (4) 3.7 (2.1–6.7) 45/523 (9) 3.6 (2.0–6.7) 9/62 (15) 3.9 (1.8–8.4)
 Deep dyspareunia when having intercourse, at least a little 101/583 (17) 23/330 (7) 3.7 (2.4–5.7) 90/521 (17) 3.7 (2.4–5.8) 11/62 (18) 3.0 (1.6–5.7)
 Vaginal lubrication when sexually aroused, no 39/577 (7) 7/333 (2) 2.9 (1.3–6.4) 37/517 (7) 2.9 (1.3–6.5) 2/60 (3) 1.6 (0.3–7.5)
 Decreased ability for intercourse leading to lower intercourse frequency, at least a little 176/575 (31) 37/327 (11) 2.9 (2.1–4.1) 160/515 (31) 2.9 (2.0–4.0) 11/60 (18) 2.5 (1.5–4.1)
 Vaginal elasticity, no 172/502 (34) 41/302 (14) 1.8 (1.3–2.4) 148/451 (33) 1.6 (1.2–2.2) 24/51 (47) 2.5 (1.7–3.7)
 Genital swelling when sexually aroused, no 82/571 (14) 35/327 (11) 1.5 (1.0–2.2) 72/512 (14) 1.5 (1.0–2.2) 10/59 (17) 1.6 (0.9–3.1)
 Superficial dyspareunia when having intercourse, at least a little 140/584 (24) 67/330 (20) 1.5 (1.2–2.0) 125/523 (24) 1.5 (1.1–2.0) 15/61 (25) 1.4 (0.8–2.2)
 Sensitivity to touch inside vagina, no 221/540 (41) 65/310 (21) 1.3 (1.0–1.6) 192/485 (40) 1.2 (1.0–1.5) 29/55 (53) 1.7 (1.3–2.2)
 Sensitivity to touch of labia and clitoris, no 186/558 (33) 61/320 (19) 1.2 (0.9–1.5) 163/501 (33) 1.1 (0.9–1.4) 23/57 (40) 1.5 (1.1–2.1)
               
Pelvic bone symptoms
 Pubic pain when walking indoors at least occasionally 46/603 (8) 6/343 (2) 4.9 (2.1–11.6) 35/542 (6) 4.1 (1.7–10.2) 11/61 (18) 10.3 (4.0–26.7)
 Pubic pain when walking outdoors 500 m at least occasionally 42/596 (7) 7/343 (2) 3.7 (1.7–8.4) 34/536 (6) 3.3 (1.4–7.7) 8/60 (13) 6.6 (2.5–17.5)
 Pubic pain, yes 67/603 (11) 12/339 (4) 3.4 (1.9–6.4) 53/544 (10) 3.0 (1.6–5.7) 14/59 (24) 7.0 (3.5–14.2)
 Hip pain, yes 212/599 (35) 113/343 (33) 1.0 (0.8–1.2) 182/538 (34) 0.9 (0.8–1.2) 30/61 (49) 1.5 (1.1–2.0)
 Hip pain when walking outdoors 500 m at least occasionally 193/598 (32) 102/340 (30) 1.0 (0.8–1.3) 165/536 (31) 1.0 (0.8–1.2) 28/62 (45) 1.5 (1.1–2.0)
 Sacral pain, yes 232/600 (39) 179/344 (52) 0.8 (0.7–0.9) 196/539 (36) 0.7 (0.6–0.8) 36/61 (59) 1.1 (0.9–1.4)
               
Lower abdomen and leg symptoms
 Erysipelas on abdomen or legs, yes 17/597 (3) 3/336 (1) 3.6 (1.0–12.8) 14/537 (3) 4.0 (1.1–14.5) 3/60 (5) 5.2 (1.1–25.1)
 Lower abdominal heaviness at least occasionally 119/600 (20) 38/344 (11) 2.1 (1.5–3.0) 101/540 (19) 2.1 (1.4–3.0) 18/60 (30) 2.7 (1.7–4.5)
 Pain in lower abdomen in connection with oedema at least occasionally 92/607 (15) 33/343 (10) 1.9 (1.3–2.8) 75/546 (14) 1.7 (1.1–2.6) 17/61 (28) 3.0 (1.8–5.0)
 Leg pain in connection with oedema at least occasionally 164/606 (27) 54/342 (16) 1.7 (1.3–2.3) 145/545 (27) 1.7 (1.2 (2.2) 19/61 (31) 2.0 (1.3–3.2)
 Swollen lower abdomen at least occasionally 121/599 (20) 51/342 (15) 1.7 (1.3–2.4) 106/538 (20) 1.8 (1.3–2.5) 15/61 (25) 1.7 (1.0–2.8)
 Protracted leg pain lasting >1 year, yes 134/593 (23) 48/339 (14) 1.5 (1.1–2.1) 115/532 (22) 1.4 (1.0–2.0) 19/61 (31) 2.2 (1.4–3.4)
 Swollen legs at least occasionally 218/606 (36) 94/344 (27) 1.4 (1.1–1.7) 197/546 (36) 1.4 (1.1–1.9) 21/60 (35) 1.4 (0.9–2.0)
 Heavy legs at least occasionally 210/606 (35) 97/344 (28) 1.1 (1.1–1.6) 186/546 (34) 1.3 (1.0–1.6) 24/60 (40) 1.4 (1.0–2.1)

Abbreviations: CI=confidence interval; RR=relative risk; RT=radiation therapy.

Bold entries indicate statistic significance. The symptoms are sorted into anatomical region of supposed origin and in size order for RR, the number in the denominator may vary because of missing information.